ASX Small Caps Report Key Milestones Across Biotech, Gold Exploration, and Critical Minerals
The S&P/ASX Small Ordinaries Index fell for the fifth consecutive day as small-cap weakness persisted. Despite this decline, several ASX-listed companies in biotechnology, gold exploration, and critical minerals announced significant developments.
Topics: biotechnology patents pharmaceuticals